Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Amendment to Performance Share Plan

14 Dec 2022 10:45

RNS Number : 6814J
DX (Group) PLC
14 December 2022
 

AIM: DX.

DX (Group) plc

("DX" or "the Group" or "the Company")

 

Company Performance Share Plan

 

DX, the provider of delivery solutions, including parcel freight, secure courier and logistics services, reports an amendment ("Amendment") to the Performance Condition of the Company's Performance Share Plan ("PSP"), which was established in December 2017 for directors and certain senior management of the Company ("Participants").

 

The Amendment introduces a further testing date of 21 December 2023, with the objective of retaining and fairly rewarding the 36 Participants, who are currently employed by the Group, in the PSP for a further year. The current third and final testing date for the PSP is on 21 December 2022 and the Amendment therefore extends the Performance Condition and adds a further measurement date in twelve months' time.

 

In light of the close proximity of the date of restoration of the Company's ordinary shares to trading on 19 October 2022 and the third testing date for the PSP under the plan on 21 December 2022, the Amendment creates additional time for the continued strong trading by the Group and its positive outlook to be recognised in a fair market price.

 

The Amendment also provides the further benefit of enabling DX to defer the implementation of a replacement Long Term Incentive Plan for a year and will help to retain and motivate the senior managers in the PSP.

 

A majority of shareholders of the Company's issued share capital, were consulted with respect to the Amendment.

 

Related party transaction

 

Under the AIM Rules for Companies, the Amendment to the PSP in relation to David Mulligan, Paul Ibbetson, Martin Illidge, Michael Sherry, and Kevin Galligan is classified as a Related Party Transaction. Accordingly, Mark Hammond, Mike Russell and Jon Kempster as Independent Directors consider, having consulted with finnCap, the Company's Nominated Adviser, that the terms of the Amendment are fair and reasonable insofar as its shareholders are concerned.

 

Enquiries:

DX (Group) plc

T: 020 3178 6378 (c/o KTZ

Jon Kempster, Senior Independent Non-executive Director

 Communications)

Mike Russell, Independent Non-executive Director

finnCap (Nominated Adviser & Joint Broker to DX)

T: 020 7220 0500

Matt Goode/Simon Hicks (Corporate Finance)

Andrew Burdis/Charlotte Sutcliffe (ECM)

 

Liberum (Joint Broker to DX)

T: 020 3100 2000

Nick How/William Hall

 

 

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis

Dan Mahoney

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANALFELAFEA
Date   Source Headline
14th Dec 20232:34 pmRNSForm 8.3 - DX GROUP PLC
14th Dec 202312:38 pmPRNForm 8.3 - DX (Group) Plc
14th Dec 202310:21 amRNSForm 8.5 (EPT/RI)
14th Dec 20239:51 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
14th Dec 20239:28 amRNSForm 8.3 - DX (Group) PLC
13th Dec 20233:30 pmGNWForm 8.3 - DX (Group) plc
13th Dec 20233:03 pmRNSForm 8.3 - DX (Group) PLC
13th Dec 20232:53 pmRNSUpdate on Letter of Intent
13th Dec 20231:32 pmPRNForm 8.3 - DX (Group) Plc
13th Dec 202311:30 amRNSForm 8.3 - DX Group PLC
13th Dec 202310:41 amRNSForm 8.5 (EPT/RI)
12th Dec 20231:54 pmPRNForm 8.3 - DX (Group) Plc
12th Dec 202311:37 amRNSForm 8.5 (EPT/RI)
11th Dec 20233:30 pmGNWForm 8.3 - DX (Group) plc
11th Dec 20233:19 pmRNSUpdate on Letter of Intent
11th Dec 202312:14 pmPRNForm 8.3 - DX (Group) Plc
11th Dec 202311:31 amRNSForm 8.5 (EPT/RI)
11th Dec 202311:09 amRNSForm 8.3 - DX Group PLC
11th Dec 20237:00 amRNSPublication and Posting of Scheme Document
8th Dec 20232:10 pmPRNForm 8.3 - DX (Group) Plc
8th Dec 202310:49 amRNSForm 8.5 (EPT/RI)
8th Dec 20239:23 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
7th Dec 20232:38 pmPRNForm 8.3 - DX (Group) Plc
7th Dec 202312:33 pmRNSRecommended Cash Acquisition Update
7th Dec 202312:18 pmRNSForm 8.3 - DX (Group) plc
7th Dec 202310:29 amRNSForm 8.5 (EPT/RI) - DX (group) Plc
7th Dec 20239:55 amRNSForm 8.5 (EPT/RI)
6th Dec 20233:30 pmGNWForm 8.3 - DX (Group) plc
6th Dec 20232:57 pmPRNForm 8.3 - DX (Group) Plc
6th Dec 202312:32 pmRNSForm 8.3 - DX Group PLC
6th Dec 202310:54 amRNSForm 8.5 (EPT/RI)
6th Dec 202310:27 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
5th Dec 20233:10 pmPRNForm 8.3 - DX (Group) Plc
5th Dec 20239:48 amRNSForm 8.5 (EPT/RI) - DX (Group) Plc
5th Dec 20239:43 amRNSForm 8.5 (EPT/RI)
4th Dec 20232:55 pmPRNForm 8.3 - DX (Group) Plc
4th Dec 20239:38 amRNSForm 8.5 (EPT/RI)
1st Dec 20239:52 amRNSForm 8.5 (EPT/RI)
30th Nov 202310:07 amRNSForm 8.5 (EPT/RI)
29th Nov 20233:30 pmGNWForm 8.3 - DX (Group) plc
29th Nov 20233:08 pmGNWForm 8.3 - [DX (Group) plc - 28 11 2023] - (CGAML)
29th Nov 20232:54 pmGNWFurther Partial Withdrawal of Letter of Intent - DX (Group) plc - 28 11 2023 (CGAML)
29th Nov 20231:15 pmPRNForm 8.3 - DX (Group) Plc
29th Nov 20231:03 pmRNSForm 8.3 - DX (Group) plc
29th Nov 20239:56 amRNSForm 8.5 (EPT/RI)
29th Nov 20239:31 amPRNForm 8.3 - DX (Group) plc
28th Nov 20235:30 pmRNSHolding(s) in Company
28th Nov 20233:30 pmGNWForm 8.3 - DX (Group) plc
28th Nov 202312:43 pmPRNForm 8.3 - DX (Group) Plc
28th Nov 202311:39 amGNWPartial Withdrawal of Letter of Intent - DX (Group) plc - 27 11 2023 - (CGAML)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.